Literature DB >> 9275079

The epidermal growth factor receptor is not required for tumor necrosis factor-alpha action in normal mammary epithelial cells.

L M Varela1, K M Darcy, M M Ip.   

Abstract

Our laboratory has shown that tumor necrosis factor-alpha (TNF alpha) can regulate normal mammary epithelial cell (MEC) growth, morphogenesis, and, under certain circumstances, functional differentiation in a manner similar to epidermal growth factor (EGF). As TNF alpha has been shown to up-regulate EGF receptor (EGFR) expression and function in other systems, the present studies were undertaken to determine whether TNF alpha action in MEC was indirect through stimulation of the EGFR. An inhibitor of EGFR tyrosine kinase activity, PD158780, failed to block proliferation induced by 40 ng/ml TNF alpha and only partially inhibited growth in response to 2 ng/ml TNF alpha. PD158780 was also unable to suppress the extensive morphological development induced by either TNF alpha concentration. In contrast, the effects of TNF alpha and PD158780 on functional differentiation (i.e. casein accumulation) were time dependent. When measured on day 7 after 48 h of treatment, casein accumulation was unaffected by either concentration of TNF alpha or by PD158780. When assessed on day 21 after 16 days of treatment, however, casein levels were decreased by 40 ng/ml TNF alpha and increased by PD158780. Significantly, this PD158780-induced increase in casein was not observed in MEC that had been treated with both PD158780 and TNF alpha. These results thus suggest that EGFR tyrosine kinase activity is not necessary for TNF alpha action in normal MEC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9275079     DOI: 10.1210/endo.138.9.5389

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB.

Authors:  Jiping Zhang; Mary Ann Warren; Suzanne F Shoemaker; Margot M Ip
Journal:  Endocrinology       Date:  2006-09-28       Impact factor: 4.736

2.  Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.

Authors:  Mark D Sternlicht; Susan W Sunnarborg; Hosein Kouros-Mehr; Ying Yu; David C Lee; Zena Werb
Journal:  Development       Date:  2005-08-03       Impact factor: 6.868

3.  MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling.

Authors:  Rehan Ahmad; Deepak Raina; Vishal Trivedi; Jian Ren; Hasan Rajabi; Surender Kharbanda; Donald Kufe
Journal:  Nat Cell Biol       Date:  2007-11-25       Impact factor: 28.824

Review 4.  The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.

Authors:  Mark D Sternlicht; Susan W Sunnarborg
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-05-10       Impact factor: 2.673

5.  The EGF receptor and HER2 participate in TNF-α-dependent MAPK activation and IL-8 secretion in intestinal epithelial cells.

Authors:  Humberto B Jijon; Andre Buret; Christina L Hirota; Morley D Hollenberg; Paul L Beck
Journal:  Mediators Inflamm       Date:  2012-09-05       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.